Complete Revascularization Benefits STEMI Patients with Most Severe Nonculprit Lesions, Study Shows
An analysis of patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease in the COMPLETE trial showed that those with more severe stenosis of nonculprit lesions gained bigger benefits from complete revascularization, in terms of cardiovascular outcomes.